Understanding pancreatic neuroendocrine tumors through protein analysis
Proteomic Characterization of Pancreatic Neuroendocrine Tumors and Metastatic Progression
This study is looking at pancreatic neuroendocrine tumors to find out more about their different types by examining the proteins in the tumors, which could help doctors better understand how to treat patients based on their risk of spreading the cancer.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10907222 on NIH RePORTER |
What this research studies
This research investigates pancreatic neuroendocrine tumors (PanNETs) by analyzing their protein profiles to identify different subtypes that may explain variations in patient outcomes. The study aims to uncover new classifications of these tumors using deep proteomic analysis, which could lead to better risk stratification and monitoring strategies. By comparing tissues from patients with low and high risk of metastasis, the research seeks to establish protein markers that could aid in early detection and treatment response. This approach may provide insights that traditional genomic methods have not achieved.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic neuroendocrine tumors, particularly those who have undergone surgical resection.
Not a fit: Patients with other types of pancreatic tumors or those who have not been diagnosed with pancreatic neuroendocrine tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved classification and monitoring of pancreatic neuroendocrine tumors, potentially enhancing treatment outcomes for patients.
How similar studies have performed: Preliminary studies have shown success in using proteomic profiling to distinguish and subclassify various tumors, indicating a promising approach for this research.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Roehrl, Michael H. a. — Beth Israel Deaconess Medical Center
- Study coordinator: Roehrl, Michael H. a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.